Mednet Logo
CommunityNeurology

How would you approach antithrombotic therapy in patients with acute ischemic infarcts and a non-occlusive intracranial thrombus?

Would you adjust your approach based on the infarct size, symptom severity, or stroke etiology?
Community PollStarted

Which antithrombotic therapy would you choose for an acute ischemic stroke patient with a non-occlusive intracranial thrombus?

91 physicians have voted

Join Mednetto vote and see how they answered.

4 Answers
Mednet Member
Mednet MemberInvited Expert
Neurology · HCA Houston Healthcare
Answered on

I agree with the previous answer and can expand on a few key management nuances involving stroke size, symptom severity, and etiology. For stroke size, I typically initiate anticoagulation (heparin drip) if less than one-third of the affected territory is involved, extrapolating from tPA guidelines....

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Neurology · Vanderbilt University Medical Center
Answered on

I am unaware of data on this question, but it makes sense that an intraluminal thrombus might cause further ischemia. I would favor a few days of IV heparin, followed by reimaging and switching to antiplatelet Rx if the thrombus has resolved.

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Neurology · University of Virginia, School of Medicine
Answered on

While there are no clinical trials that guide us to what the best approach is. I usually try to discern first if what we see is atherosclerotic stenosis or a non-occlusive thrombus. If someone had a prior CTA or MRA available then I would compare the vessels in terms of if there was prior stenosis o...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Neurology · University of Minnesota
Answered on

Post the stroke mentioned, I would use 2 platelet inhibitors for 4 weeks, then usually ASA alone.

Join for free or sign in to see the full answer